These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 18465194

  • 1. Periostin and bone marrow fibrosis.
    Oku E, Kanaji T, Takata Y, Oshima K, Seki R, Morishige S, Imamura R, Ohtsubo K, Hashiguchi M, Osaki K, Yakushiji K, Yoshimoto K, Ogata H, Hamada H, Izuhara K, Sata M, Okamura T.
    Int J Hematol; 2008 Jul; 88(1):57-63. PubMed ID: 18465194
    [Abstract] [Full Text] [Related]

  • 2. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice.
    Ozono Y, Shide K, Kameda T, Kamiunten A, Tahira Y, Sekine M, Akizuki K, Nakamura K, Iwakiri H, Sueta M, Hidaka T, Kubuki Y, Yamamoto S, Hasuike S, Sawaguchi A, Nagata K, Shimoda K.
    Leukemia; 2021 Feb; 35(2):454-467. PubMed ID: 32472085
    [Abstract] [Full Text] [Related]

  • 3. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.
    Bock O, Höftmann J, Theophile K, Hussein K, Wiese B, Schlué J, Kreipe H.
    Am J Pathol; 2008 Apr; 172(4):951-60. PubMed ID: 18349123
    [Abstract] [Full Text] [Related]

  • 4. CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis.
    Leguit RJ, Broekhuizen R, de Witte M, Raymakers RAP, Goldschmeding R.
    Virchows Arch; 2024 May; 484(5):837-845. PubMed ID: 38602559
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
    Nakayama S, Yokote T, Hiraoka N, Akioka T, Nishiwaki U, Miyoshi T, Iwaki K, Fumimoto A, Masuda Y, Hatooka J, Fujimoto M, Nishimura Y, Tsuji M.
    Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
    [Abstract] [Full Text] [Related]

  • 6. Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia.
    Chou JM, Li CY, Tefferi A.
    Leuk Res; 2003 Jun; 27(6):499-504. PubMed ID: 12648509
    [Abstract] [Full Text] [Related]

  • 7. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
    Åström M, Hahn-Strömberg V, Zetterberg E, Vedin I, Merup M, Palmblad J.
    Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
    [Abstract] [Full Text] [Related]

  • 8. Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis.
    Desterke C, Martinaud C, Guerton B, Pieri L, Bogani C, Clay D, Torossian F, Lataillade JJ, Hasselbach HC, Gisslinger H, Demory JL, Dupriez B, Boucheix C, Rubinstein E, Amsellem S, Vannucchi AM, Le Bousse-Kerdilès MC.
    Haematologica; 2015 Jun; 100(6):757-67. PubMed ID: 25840601
    [Abstract] [Full Text] [Related]

  • 9. Deposition of transforming growth factor-beta in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-beta by leukemic cells.
    Johnston JB, Dalal BI, Israels SJ, Oh S, McMillan E, Begleiter A, Michaud G, Israels LG, Greenberg AH.
    Am J Clin Pathol; 1995 May; 103(5):574-82. PubMed ID: 7741102
    [Abstract] [Full Text] [Related]

  • 10. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
    Wang JC, Chang TH, Goldberg A, Novetsky AD, Lichter S, Lipton J.
    Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
    [Abstract] [Full Text] [Related]

  • 11. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.
    Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, McKenzie AN, Nagai H, Hotokebuchi T, Izuhara K.
    J Allergy Clin Immunol; 2006 Jul; 118(1):98-104. PubMed ID: 16815144
    [Abstract] [Full Text] [Related]

  • 12. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
    Shehata M, Schwarzmeier JD, Hilgarth M, Hubmann R, Duechler M, Gisslinger H.
    J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
    Rambaldi B, Diral E, Donsante S, Di Marzo N, Mottadelli F, Cardinale L, Dander E, Isimbaldi G, Pioltelli P, Biondi A, Riminucci M, D'Amico G, Elli EM, Pievani A, Serafini M.
    Ann Hematol; 2021 Jan; 100(1):105-116. PubMed ID: 33089365
    [Abstract] [Full Text] [Related]

  • 14. Systemic transforming growth factor-beta in patients with bone marrow fibrosis--pathophysiological implications.
    Rameshwar P, Chang VT, Thacker UF, Gascón P.
    Am J Hematol; 1998 Oct; 59(2):133-42. PubMed ID: 9766798
    [Abstract] [Full Text] [Related]

  • 15. Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.
    Gleitz HFE, Dugourd AJF, Leimkühler NB, Snoeren IAM, Fuchs SNR, Menzel S, Ziegler S, Kröger N, Triviai I, Büsche G, Kreipe H, Banjanin B, Pritchard JE, Hoogenboezem R, Bindels EM, Schumacher N, Rose-John S, Elf S, Saez-Rodriguez J, Kramann R, Schneider RK.
    Blood; 2020 Oct 29; 136(18):2051-2064. PubMed ID: 32726410
    [Abstract] [Full Text] [Related]

  • 16. Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-beta.
    Rameshwar P, Denny TN, Stein D, Gascón P.
    J Immunol; 1994 Sep 15; 153(6):2819-30. PubMed ID: 7521370
    [Abstract] [Full Text] [Related]

  • 17. S100 expression by atypical megakaryocytes: a previously unreported potential pitfall in dermatopathology.
    Fernandez-Flores A, Díaz-Galvez FJ.
    J Cutan Pathol; 2014 Dec 15; 41(12):963-8. PubMed ID: 25371084
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis.
    Martyré MC, Romquin N, Le Bousse-Kerdiles MC, Chevillard S, Benyahia B, Dupriez B, Demory JL, Bauters F.
    Br J Haematol; 1994 Sep 15; 88(1):9-16. PubMed ID: 7803262
    [Abstract] [Full Text] [Related]

  • 19. The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.
    Uchiyama T, Kawabata H, Miura Y, Yoshioka S, Iwasa M, Yao H, Sakamoto S, Fujimoto M, Haga H, Kadowaki N, Maekawa T, Takaori-Kondo A.
    Cancer Med; 2015 Oct 15; 4(10):1558-72. PubMed ID: 26276681
    [Abstract] [Full Text] [Related]

  • 20. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O, Loch G, Schade U, von Wasielewski R, Schlué J, Kreipe H.
    J Pathol; 2005 Apr 15; 205(5):548-57. PubMed ID: 15726648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.